Clinical Trial Update: Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease [Phase 2]

View source ↗

Summary

The document reports termination of a Phase 2 study evaluating denufosol inhalation solution in patients with mild-to-moderate cystic fibrosis lung disease. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Denufosol inhalation solution (denufosol tetra-sodium)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED